Halozyme Reports Fourth Quarter And Full Year 2015 Financial Results

Go back to Halozyme Reports Fourth Quarter And Full Year 2015 Financial Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 108.64 +0.47 (0.43%)
Previous Close $108.17    52 Week High $18.39 
Open $108.00    52 Week Low $6.96 
Day High $109.10    P/E N/A 
Day Low $106.87    EPS $-0.58 
Volume 2,091,283